These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. Hayashida T; Decaestecker M; Schnaper HW FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291 [TBL] [Abstract][Full Text] [Related]
7. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1. Kim YK; Bae GU; Kang JK; Park JW; Lee EK; Lee HY; Choi WS; Lee HW; Han JW Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845 [TBL] [Abstract][Full Text] [Related]
12. The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle. Rostam MA; Kamato D; Piva TJ; Zheng W; Little PJ; Osman N Cell Signal; 2016 Aug; 28(8):956-66. PubMed ID: 27153775 [TBL] [Abstract][Full Text] [Related]
13. p21-Activated kinase 2 (PAK2) inhibits TGF-β signaling in Madin-Darby canine kidney (MDCK) epithelial cells by interfering with the receptor-Smad interaction. Yan X; Zhang J; Sun Q; Tuazon PT; Wu X; Traugh JA; Chen YG J Biol Chem; 2012 Apr; 287(17):13705-12. PubMed ID: 22393057 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells. Kamato D; Rostam MA; Piva TJ; Babaahmadi Rezaei H; Getachew R; Thach L; Bernard R; Zheng W; Little PJ; Osman N J Pharm Pharmacol; 2014 Dec; 66(12):1722-33. PubMed ID: 25316549 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA. Zhao BM; Hoffmann FM Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures. Wilkes MC; Leof EB J Biol Chem; 2006 Sep; 281(38):27846-54. PubMed ID: 16867995 [TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. Wang S; Wilkes MC; Leof EB; Hirschberg R FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889 [TBL] [Abstract][Full Text] [Related]
18. Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β). Lin S; Yu L; Yang J; Liu Z; Karia B; Bishop AJR; Jackson J; Lozano G; Copland JA; Mu X; Sun B; Sun LZ J Biol Chem; 2011 Dec; 286(51):44023-44034. PubMed ID: 22039050 [TBL] [Abstract][Full Text] [Related]
19. ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells. Hong HK; Song CY; Kim BC; Lee HS Transl Res; 2006 Oct; 148(4):171-9. PubMed ID: 17002919 [TBL] [Abstract][Full Text] [Related]
20. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells. Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]